Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-06-06

Clinical Trial Update: The Impact of a Preoperative Nerve Block in Foot and Ankle Surgery on the Consumption of Sevoflurane [Phase 2, Phase 3]

View source ↗

Summary

The University of Alberta's Phase 2/Phase 3 trial evaluating a preoperative nerve block to reduce sevoflurane consumption in foot and ankle surgery has been wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: University of Alberta | Conditions: Ankle Arthropathy, Anesthesia; Functional | Phase 2, Phase 3 | Status: WITHDRAWN